Testing for endothelial dysfunction

Annals of Medicine

Volumn 32, Issue 5, 2000, Pages 293-304

  Raitakari, O T ^a   Celermajer, D S ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Atherosclerosis; Endothelial physiology; Vascular health

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; PADGEM PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ATHEROSCLEROSIS; BLOOD VESSEL TONE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; CORONARY RISK; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FOREARM BLOOD FLOW; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTRAVASCULAR ULTRASOUND; LEUKOCYTE ADHERENCE; OXIDATION REDUCTION POTENTIAL; PATHOPHYSIOLOGY; PLETHYSMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; REVIEW; RISK ASSESSMENT; RISK FACTOR; VASCULAR ENDOTHELIUM; VASOMOTOR REFLEX;

EID: 0033930185     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853890008995931     Document Type: Review

References (123)

1. Endothelial dysfunction: Does it matter? Is it reversible?
2. The pathogenesis of atherosclerosis: A perspective for the 1990s
3. Choices among the possible reaction routes catalyzed by thrombin
4. Biological importance of prostacyclin
5. Cell biology of endothelial cells
6. Endothelium and control of vascular function
7. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
8. Vascular endothelial cells synthesize nitric oxide from L-arginine
9. Effects of endothelium-derived nitrix oxide on peripheral arteriolar tone in man
10. Role of endothelium in the maintenance of low pulmonary vascular tone in normal children
11. Crucial role of endothelium in the vasodilator response to increased flow in-vivo
12. Endothelium-derived relaxing factor alters calcium fluxes in rabbit aorta: A cyclic guanosine monophosphate-mediated effect
13. The role of endothelium in cardiovascular homeostasis and diseases
14. Thromboatherosclerosis in normolipemic rabbits; a result of continued endothelial damage
15. A technique to investigate surface morphology and endothelial cell replication of small arteries; a study in acute angiotensin-induced hypertension
16. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction
17. Effect of 1p(a) on the early functional and structural changes of atherosclerosis
18. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults
19. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults
20. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels
21. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
22. Coronary flow reserve is reduced in young men with insulin-dependent diabetes mellitus
23. Lipoproteins and the pathogenesis of atherosclerosis
24. Endothelium in control
25. Hypercholesterolemia increases endothelial superoxide anion production
26. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia
27. Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease
28. Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris
29. Coronary angiographic changes with lovastatin therapy: The monitored atherosclerosis regression study (MARS)
30. Is NO an endogenous antiatherogenic molecule?
31. Nanogram nitrate and nitrate determination in environmental and biological materials by vanadium (III) reduction with chemiluminescene detection
32. Quantification of nitrite and nitrate in human urine and plasma as pentafluorobenzyl derivatives by gas chromatography-mass spectrometry using their 15N-labelled analogs
33. Nitric oxide as a challenge for the clinical chemistry laboratory
34. Metabolism and excretion of nitric oxide in humans: An experimental and clinical study
35. The L-arginine-nitric oxide pathway
36. Biosynthesis and metabolism of endothelium-derived nitric oxide
37. Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production
38. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial disease
39. Effects of diet on measurements of nitric oxide metabolites
40. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries
41. Endothelial function in human coronary arteries in vivo
42. Coronary vasomotor response to acetyl-choline relates to risk factors for coronary artery disease
43. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis
44. Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise
45. Large coronary arteries in humans are responsive to changing blood flow: An endothelium-dependent mechanism that fails in patients with atherosclerosis
46. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
47. Prognostic impact of coronary vasodilator function on adverse long-term outcome of coronary heart disease
48. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
49. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans
50. Abnormal endothelium-dependent vascular reaction in patients with essential hypertension
51. The pharmacology of human blood vessels in vivo
52. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus
53. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension
54. Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients. A randomized, placebo-controlled, double- blind study
55. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis
56. Coronary flow reserve is impaired in young men with hypercholesterolemia
57. Coronary flow reserve in young men with familial combined hypercholesterolemia
58. Early impairment of coronary flow reserve in young men with borderline hypertension
59. In vivo LDL oxidation relates to coronary reactivity in young men
60. Influence of cardiovascular risk profile on coronary flow reserve in healthy young men
61. Influence of subclinical atherosclerosis on coronary flow reserve in young men
62. Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve
63. Effect of short term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reserve
64. Different endothelial mechanisms involved in coronary responses to known vasodilators
65. Endothelium-dependent responses of cerebral arterioles to adenosine 5'- disphosphate
66. Flow-induced release of endothelium-derived relaxing factor
67. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilatation in adults at risk of atherosclerosis
68. L-arginine normalizes coronary vasomotion in long-term smokers
69. Noninvasive assessment of significant left anterior descending coronary artery stenosis by coronary flow velocity reserve with transthoracic color Doppler
70. Assessment of myocardial perfusion by intermittent harmonic power Doppler using Sono Vue, a new ultrasound contrast agent
71. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo
72. Close relationship of endothelial function in the human coronary and peripheral circulations
73. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease
74. Non-invasive measurement of endothelium-dependent arterial responses in man: Accuracy and reproducibility
75. Endothelial function of peripheral arteries: A window for presymptomatic detection of atherosclerosis?
76. Passive-smoke related arterial endothelial dysfunction is potentially reversible in healthy young adults
77. Non-invasive detection of endothelial dysfunction in patients with essential hypertension
78. Impaired endothelial with essential hypertension assessed by ultrasonography
79. Aging is related with endothelial dysfunction in healthy men years before the age-related decline in women
80. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and LDL-cholesterol levels
81. Hyperhomocysteinemia is a risk factor for arterial dysfunction in humans
82. Biological significance of endogenous methylargines that inhibit nitric oxide synthase
83. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits
84. Endogenous nitric oxide synthase inhibitor. A novel marker of atherosclerosis
85. Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia
86. Novel mechanism for endothelial dysfunction. Dys-regulation of dimethylarginine dimethylaminohydrolase
87. The role of endothelin in coronary atherosclerosis
88. Circulation and tissue endothelin immunoreactivity in advanced atherosclerosis
89. Elevated endothelin levels in patients with hyperlipoproteinemia
90. Elevated endothelin-1 levels after cigarette smoking
91. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium
92. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans
93. Von Willebrand Factor. A marker of endothelial damage?
94. Von Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death
95. The PLAT Study: Hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients: Principal results
96. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
97. Reduction in cholesterol is associated with reduction in von Willebrand factor
98. Concentration of endogenous tPA antigen in coronary artery disease. Relation to thrombotic events, aspirin treatment, hyperlipidemia, and multivessel disease
99. Endogenous tissue-type plasminogen activator and risk of myocardial infarction
100. Prospective study of endogenous tissue plasminogen activator and risk of stroke
101. Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study
102. Increased fibrinolytic activity in the intima of atheromatous coronary arteries: Protection at a price
103. Fatty streaks and fibrous plaques in human aorta show increased plasminogen activator activity
104. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature
105. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: A mechanism for arterial thrombosis and myocardial infarction
106. Correlations between t-PA and PAI-1 antigen and activity and t-PA/PAI-1 complexes in plasma of control subjects and patients with increased t-PA and PAI-1 levels
107. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cell
108. Atherosclerosis - an inflammatory disease
109. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium
110. E-selectin and inter-cellular adhesion molecule-1 are released by activated human endothelial cells in vitro
111. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells
112. Lysophosphatidyl-choline, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured endothelial cells
113. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk in Communities (ARIC) Study
114. Thrombolytic therapy with urokinase reduces increased circulating endothelial adhesion molecules in acute myocardial infarction
115. Increased soluble form P-selectin in patients with unstable angina
116. Soluble form of P-selectin in patients with acute myocardial infarction
117. Soluble P-selectin is released into the coronary circulation after coronary spasm
118. Increased levels of soluble P-selectin in hypercholesterolemic patients
119. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis
120. Plasma concentrations of soluble intercellular adhesion molecule 1 and risk of future myocardial infarction in apparently healthy men
121. Levels of soluble cell adhesion molecules in patients with dyslipidemia
122. Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia